2017
HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials
Tien C, Carlson D, Nath R, Chen Z. HDR Monotherapy in Prostate Cancer: Radiobiological Considerations When Determining Biologically Effective Dose in Clinical Trials. Brachytherapy 2017, 16: s31. DOI: 10.1016/j.brachy.2017.04.038.Peer-Reviewed Original Research
2014
Motion management in gastrointestinal cancers
Abbas H, Chang B, Chen ZJ. Motion management in gastrointestinal cancers. Journal Of Gastrointestinal Oncology 2014, 5: 223-35. PMID: 24982771, PMCID: PMC4074952, DOI: 10.3978/j.issn.2078-6891.2014.028.Peer-Reviewed Original Research
2010
Response to “Comment on ‘AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137’” [Med. Phys. 36, 5310–5322 (2009)]
Nath R, Bice WS, Butler WM, Chen Z, Meigooni AS, Narayana V, Rivard MJ, Yu Y. Response to “Comment on ‘AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: Report of Task Group 137’” [Med. Phys. 36, 5310–5322 (2009)]. Medical Physics 2010, 37: 1933-1933. PMID: 20443515, DOI: 10.1118/1.3358143.Peer-Reviewed Original Research
2009
Impact of Kilo-Voltage Cone Beam Computed Tomography on Image-Guided Radiotherapy of Prostate Cancer
Deng J, Chen Z, Nath R. Impact of Kilo-Voltage Cone Beam Computed Tomography on Image-Guided Radiotherapy of Prostate Cancer. IFMBE Proceedings 2009, 25/1: 17-20. DOI: 10.1007/978-3-642-03474-9_5.Peer-Reviewed Original ResearchKilo-voltage cone beamProstate cancerImage-guided radiotherapyDosevolume histogramsExcessive dosesCone beamFemur headAdjacent critical structuresPatient anatomyTesticular doseCBCT dosesTesticular dosesImage-guided radiation therapyRadiation therapyMost dosesSuperior-inferior directionDVH analysisCritical organsCancerDosesIGRT treatmentReal patient anatomyDosimetric impactScanning protocolPosterior side
2008
A preliminary report on AAPM guidelines on the physics of dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer
Nath R, Bice W, Butler W, Chen Z, Meigooni A, Narayana V, Rivard M, Yu Y. A preliminary report on AAPM guidelines on the physics of dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer. Brachytherapy 2008, 7: 132. DOI: 10.1016/j.brachy.2008.02.123.Peer-Reviewed Original Research
1998
Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants
Nath R, Roberts K, Ng M, Peschel R, Chen Z. Correlation of medical dosimetry quality indicators to the local tumor control in patients with prostate cancer treated with iodine‐125 interstitial implants. Medical Physics 1998, 25: 2293-2307. PMID: 9874821, DOI: 10.1118/1.598440.Peer-Reviewed Original ResearchConceptsSurvival rateProstate cancerInterstitial implantsLocal recurrence-free survival rateRecurrence-free survival ratesLocal control rateLocal tumor controlExcellent clinical resultsProstate cancer patientsUnfavorable groupClinical efficacyCancer patientsControl rateTumor controlClinical resultsFavorable groupDose coveragePatientsDosimetric parametersDosimetry parametersIsodose surfaceSignificant differencesVirginia studyUnfavorable parametersCancer